EE200200394A - Indooli derivaadid kui MCP-1 retseptori antagonistid - Google Patents

Indooli derivaadid kui MCP-1 retseptori antagonistid

Info

Publication number
EE200200394A
EE200200394A EEP200200394A EEP200200394A EE200200394A EE 200200394 A EE200200394 A EE 200200394A EE P200200394 A EEP200200394 A EE P200200394A EE P200200394 A EEP200200394 A EE P200200394A EE 200200394 A EE200200394 A EE 200200394A
Authority
EE
Estonia
Prior art keywords
mcp
receptor antagonists
indole derivatives
indole
derivatives
Prior art date
Application number
EEP200200394A
Other languages
English (en)
Estonian (et)
Inventor
Wellington Faull Alan
Grant Kettle Jason
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200394A publication Critical patent/EE200200394A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
EEP200200394A 2000-01-13 2001-01-11 Indooli derivaadid kui MCP-1 retseptori antagonistid EE200200394A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000626.2A GB0000626D0 (en) 2000-01-13 2000-01-13 Chemical compounds
PCT/GB2001/000069 WO2001051466A1 (en) 2000-01-13 2001-01-11 Indole derivatives as mcp-1 receptor antagonists

Publications (1)

Publication Number Publication Date
EE200200394A true EE200200394A (et) 2003-12-15

Family

ID=9883551

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200394A EE200200394A (et) 2000-01-13 2001-01-11 Indooli derivaadid kui MCP-1 retseptori antagonistid

Country Status (25)

Country Link
US (1) US20030144339A1 (enExample)
EP (1) EP1252142A1 (enExample)
JP (1) JP2003519683A (enExample)
KR (1) KR20020064375A (enExample)
CN (1) CN1395565A (enExample)
AR (1) AR026839A1 (enExample)
AU (1) AU780992B2 (enExample)
BG (1) BG106894A (enExample)
BR (1) BR0107404A (enExample)
CA (1) CA2393592A1 (enExample)
CO (1) CO5271703A1 (enExample)
EE (1) EE200200394A (enExample)
GB (1) GB0000626D0 (enExample)
HK (1) HK1049486A1 (enExample)
HU (1) HUP0300694A3 (enExample)
IL (1) IL150272A0 (enExample)
IS (1) IS6429A (enExample)
MX (1) MXPA02006611A (enExample)
NO (1) NO20023380L (enExample)
NZ (1) NZ519312A (enExample)
PL (1) PL356031A1 (enExample)
RU (1) RU2002121636A (enExample)
SK (1) SK10072002A3 (enExample)
WO (1) WO2001051466A1 (enExample)
ZA (1) ZA200204354B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
WO2004069809A1 (en) * 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
WO2006030946A1 (ja) * 2004-09-13 2006-03-23 Kureha Corporation 熱発泡性マイクロスフェアー、その製造方法、その使用、それを含む組成物、及び物品
DE602006010433D1 (de) 2005-12-09 2009-12-24 Hoffmann La Roche Für die behandlung von obesitas geeignete tricyclische amidderivate
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
US7507736B2 (en) 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
DK2134685T3 (en) * 2007-04-16 2015-12-07 Abbvie Inc 7-unsubstituted indole derivatives as MCL-1 inhibitors
WO2023224981A1 (en) * 2022-05-17 2023-11-23 Inipharm, Inc. Hsd17b13 inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529724A (en) * 1983-10-11 1985-07-16 Mcneilab, Inc. 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5273980A (en) * 1991-09-30 1993-12-28 Merck Frosst Canada Inc. Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US5686481A (en) * 1993-12-21 1997-11-11 Smithkline Beecham Corporation Endothelin receptor antagonists
US5482960A (en) * 1994-11-14 1996-01-09 Warner-Lambert Company Nonpeptide endothelin antagonists
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
JP2000507556A (ja) * 1996-03-28 2000-06-20 スミスクライン・ビーチャム・コーポレイション ケモカインのカルボン酸インドール阻害剤
JP2000516611A (ja) * 1996-08-14 2000-12-12 ワーナー―ランバート・コンパニー Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9902461D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AU780992B2 (en) 2005-04-28
AU2532401A (en) 2001-07-24
CA2393592A1 (en) 2001-07-19
WO2001051466A1 (en) 2001-07-19
IS6429A (is) 2002-06-19
KR20020064375A (ko) 2002-08-07
CN1395565A (zh) 2003-02-05
HK1049486A1 (zh) 2003-05-16
HUP0300694A2 (hu) 2003-07-28
ZA200204354B (en) 2003-09-01
CO5271703A1 (es) 2003-04-30
RU2002121636A (ru) 2004-01-10
HUP0300694A3 (en) 2005-08-29
JP2003519683A (ja) 2003-06-24
EP1252142A1 (en) 2002-10-30
BR0107404A (pt) 2002-10-08
SK10072002A3 (sk) 2003-06-03
NO20023380L (no) 2002-09-03
US20030144339A1 (en) 2003-07-31
AR026839A1 (es) 2003-02-26
NO20023380D0 (no) 2002-07-12
MXPA02006611A (es) 2002-09-30
PL356031A1 (en) 2004-06-14
IL150272A0 (en) 2002-12-01
BG106894A (bg) 2003-04-30
GB0000626D0 (en) 2000-03-01
NZ519312A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE328871T1 (de) 4-phenyl-pyridin-derivate verwendbar als neurokinin-1 rezeptor antagonisten
ATE400558T1 (de) Metabotropische glutamatrezeptor-antagonisten
NO20013809L (no) Indolderivater og anvendelse derav som MCP-1 antagonister
CY2010003I1 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
EE200200612A (et) Tsükloheksüülamiini derivaadid kui alatüübi selektiivsed NMDA-retseptori antagonistid
IL153837A0 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
DE69939053D1 (de) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives als muskarin-rezeptor antagonisten
NO20016077L (no) Makrofag-oppfanger-reseptorantagonister
NO20016053L (no) IL-8 reseptor-antagonister
EE200200394A (et) Indooli derivaadid kui MCP-1 retseptori antagonistid
ATE244716T1 (de) Neue n-triazolylmethyl-piperazinderivate als neurokininrezeptor-antagonisten
NO20016052L (no) IL-8-reseptor-antagonister
DE60130000D1 (de) Zwitterionische tachykinin-rezeptor-antagonisten
DK1180028T3 (da) IL-8-receptorantagonister
NO20015774D0 (no) IL-8 reseptorantagonister
SE0003996D0 (sv) Receptorantagonister
NO20016102L (no) IL-8 reseptorantagonister
NO20016065D0 (no) IL-8-reseptor-antagonister
DK1131291T3 (da) 4-aroyl-piperidin-CCR-3-receptorantagonister III